SCHEMBL20164527

SCHEMBL20164527

CCCNc1nc(N(C)C)nc2c(NCCCO)ncnc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 5/20 0.52
KDM4E B2RXH2 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
CYP1A2 P05177 1/20 0.39
CDK1 P06493 3/20 0.38
AURKB Q96GD4 2/20 0.38
CCNB2 O95067 2/20 0.38
CCNB1 P14635 2/20 0.38
CCNB3 Q8WWL7 2/20 0.38
PLK4 O00444 1/20 0.38
AURKA O14965 1/20 0.38
DCLK1 O15075 1/20 0.38
ROCK2 O75116 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
FES P07332 1/20 0.38
ROS1 P08922 1/20 0.38
FGFR1 P11362 1/20 0.38
PHKG2 P15735 1/20 0.38
PRKACA P17612 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20164424 0.99 SLC29A1 (0.51) SLC29A1KDM4ESMN1; SMN2CYP1A2CDK1
SCHEMBL20164445 0.92 SLC29A1 (0.55) SLC29A1KDM4ESMN1; SMN2CYP1A2KHK
Hydrochloric Acid SCHEMBL20164699 0.91 SLC29A1 (0.53) SLC29A1KDM4ESMN1; SMN2CYP1A2KHK
SCHEMBL20164618 0.83 SLC29A1 (0.45) SLC29A1KDM4ESMN1; SMN2CDK1CCNB2
SCHEMBL20164646 0.83 SLC29A1 (0.44) SLC29A1KDM4ESMN1; SMN2CDK1CCNB2
SCHEMBL20164498 0.83 SLC29A1 (0.44) SLC29A1KDM4ECDK1CCNB2CCNB1
Hydrochloric Acid SCHEMBL20164447 0.82 SLC29A1 (0.44) SLC29A1KDM4ESMN1; SMN2CDK1CCNB2
SCHEMBL25378008 0.82 SLC29A1 (0.43) SLC29A1KDM4ESMN1; SMN2CDK1CCNB2
Hydrochloric Acid SCHEMBL20164760 0.82 SLC29A1 (0.43) SLC29A1KDM4ESMN1; SMN2CDK1CCNB2
Hydrochloric Acid SCHEMBL20164588 0.82 SLC29A1 (0.43) SLC29A1KDM4ECDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180141953-A1 Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same NEURAD LTD. (IL) 2018-05-24 US claimed
US-20250057848-A1 GAL475 COMPOSITIONS AND METHODS OF USE THEREOF NEURIM PHARMACEUTICALS (1991) LTD. (IL) 2025-02-20 US disclosed
EP-3316890-B1 NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF MAKING AND USING SAME NEURAD LTD (IL) 2023-09-06 EP disclosed
US-10294228-B2 Breathing control modulating compounds, and methods of making and using same NEURAD LTD. (IL) 2019-05-21 US disclosed
US-20180141953-A1 Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same NEURAD LTD. (IL) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141953-A1 Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same MTNR1B, CHRM3, PER2 SLC29A1 4472/4885KDM4E 2168/4885SMN1; SMN2 463/4885
US-20250057848-A1 GAL475 COMPOSITIONS AND METHODS OF USE THEREOF GPR119, GPR35, GPR55 SLC29A1 2077/4885KDM4E 4205/4885SMN1; SMN2 2409/4885
US-10294228-B2 Breathing control modulating compounds, and methods of making and using same MTNR1B, PDE3A, CHRM3 SLC29A1 4518/4885KDM4E 2353/4885SMN1; SMN2 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.